Similar articles

• Sendai virus for gene therapy and vaccination.

  Griesenbach U, Inoue M, Hasegawa M, Alton EW. Griesenbach U, et al. Curr Opin Mol Ther. 2005 Aug;7(4):346-52. Curr Opin Mol Ther. 2005. PMID: 16121700 Review.
• Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.

  Inoue M, Tokusumi Y, Ban H, Shirakura M, Kanaya T, Yoshizaki M, Hironaka T, Nagai Y, Iida A, Hasegawa M. Inoue M, et al. J Gene Med. 2004 Oct;6(10):1069-81. doi: 10.1002/jgm.597. J Gene Med. 2004. PMID: 15386740
• Sendai virus vectors as an emerging negative-strand RNA viral vector system.

  Bitzer M, Armeanu S, Lauer UM, Neubert WJ. Bitzer M, et al. J Gene Med. 2003 Jul;5(7):543-53. doi: 10.1002/jgm.426. J Gene Med. 2003. PMID: 12825193 Review.
• [Development of Sendai virus vectors and their application to the fields of medical care and biotechnology].

  Iida A. Iida A. Tanpakushitsu Kakusan Koso. 2007 Aug;52(10 Suppl):1274-80. Tanpakushitsu Kakusan Koso. 2007. PMID: 17824252 Review. Japanese. No abstract available.
• In vivo repopulation of cytoplasmically gene transferred hematopoietic cells by temperature-sensitive mutant of recombinant Sendai viral vector.

  Yoshida K, Yonemitsu Y, Tanaka S, Yoshida S, Shibata S, Kondo H, Okano S, Ishikawa F, Akashi K, Inoue M, Hasegawa M, Sueishi K. Yoshida K, et al. Biochem Biophys Res Commun. 2007 Sep 28;361(3):811-6. doi: 10.1016/j.bbrc.2007.07.111. Epub 2007 Jul 30. Biochem Biophys Res Commun. 2007. PMID: 17678616